Fulgent Corp (FLGT): Bathi resik saben saham (EPS TTM)

Fulgent Genetics, Inc. (FLGT) generates revenue based on the diagnosis of rare pathologies and cancer screening. The rolling annual EPS chart visualizes the dynamics of these processes, where the -3.10 mark characterizes this parameter. Efficiency is supported by AI-powered robotic sequencing, while turnaround time precision is ensured by a sophisticated courier delivery system for transporting biomaterials to central laboratories.

FLGT Bathi resik saben saham sajrone patang kuartal pungkasan Fulgent (04.07.2022 - 14.11.2026)

Ringkesan rincian data analitis Fulgent (FLGT)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Fulgent Genetics Inc|FLGT - Target median analis

- data kapitalisasi bursa:

Kapitalisasi pasar Fulgent Genetics|FLGT - Rega Tumbas Perusahaan

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham Fulgent Genetics|FLGT - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku fulgentgenetics.com|FLGT - Nilai Total Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Rasio Total Utang marang Ekuitas Fulgent Genetics, Inc.|FLGT - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Fulgent Genetics, Inc.|FLGT - Utang perusahaan|Utang-utang marang kapitalisasi buku Fulgent Corp|FLGT - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Fulgent Genetics|Likuiditas cepet fulgentgenetics.com

- data bathi lan kelipatan valuasi:

FLGT - Bathi perusahaan|Bathi mangsa ngarep Fulgent Genetics, Inc.|FLGT - Rasio rega pasar marang bathi resik|Prakiraan rega marang bathi Fulgent Corp|FLGT - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Fulgent Corp|FLGT - Bathi operasional sadurunge potongan amortisasi|Bathi resik saben saham (EPS TTM) Fulgent Genetics|FLGT - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan fulgentgenetics.com|FLGT - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Fulgent Genetics, Inc.

- data total pendapatan lan volume dodolan:

FLGT - Total pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Fulgent Genetics, Inc.|FLGT - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S Fulgent Genetics

Pambiji fundamental perusahaan:fulgentgenetics.com (FLGT)

The efficiency of Fulgent Genetics, Inc. (FLGT) in the DNA analysis and oncology screening segment directly determines the final net income allocated per share. By analyzing the annual EPS TTM snapshot on the GURU.Markets platform, an investor can observe the adjusted 12-month profit trend without quarterly lags, allowing for an objective assessment of the company's fundamental value and investment grade while eliminating emotional market distortions.

Analisis perusahaan pesaing